GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (OTCPK:ABDXF) » Definitions » Net Cash per Share

Abingdon Health (Abingdon Health) Net Cash per Share : $-0.01 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Abingdon Health Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Abingdon Health's Net Cash per Share for the quarter that ended in Dec. 2023 was $-0.01.

The historical rank and industry rank for Abingdon Health's Net Cash per Share or its related term are showing as below:

During the past 6 years, the highest Price-to-Net-Cash Ratio of Abingdon Health was 15.70. The lowest was 6.50. And the median was 11.10.

ABDXF's Price-to-Net-Cash is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 7.195
* Ranked among companies with meaningful Price-to-Net-Cash only.

Abingdon Health Net Cash per Share Historical Data

The historical data trend for Abingdon Health's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Net Cash per Share Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Net Cash per Share
Get a 7-Day Free Trial - -0.05 -0.10 -0.04 -

Abingdon Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 -0.04 0.01 - -0.01

Competitive Comparison of Abingdon Health's Net Cash per Share

For the Diagnostics & Research subindustry, Abingdon Health's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abingdon Health's Price-to-Net-Cash Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Abingdon Health's Price-to-Net-Cash falls into.



Abingdon Health Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Abingdon Health's Net Cash per Share for the fiscal year that ended in Jun. 2023 is calculated as

Net Cash per Share (A: Jun. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(4.086-3.854-0)/121.717
=0.00

Abingdon Health's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

Net Cash per Share (Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(2.529-3.808-0)/121.717
=-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abingdon Health  (OTCPK:ABDXF) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Abingdon Health Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Abingdon Health's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Abingdon Health (Abingdon Health) Business Description

Traded in Other Exchanges
Address
York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (Abingdon Health) Headlines

From GuruFocus

AbC-19� Rapid Test Available for Purchase by Healthcare Professionals

By Business Wire Business Wire 02-16-2021